Prime Medicine (PRME) Institutional Ownership → He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (From InvestorPlace) (Ad) Free PRME Stock Alerts $7.08 +0.04 (+0.57%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media Institutional Ownership Changes (13F Filings) for Prime Medicine (NYSE:PRME)CurrentInstitutional OwnershipPercentage70.37%Number ofInstitutional Buyers(last 12 months)34TotalInstitutional Inflows(last 12 months)$91.32MNumber ofInstitutional Sellers(last 12 months)13TotalInstitutional Outflows(last 12 months)$34.09M Get PRME Insider Trade Alerts Want to know when executives and insiders are buying or selling Prime Medicine stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PRME Institutional Buying and Selling by Quarter Ad InvestorPlaceHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs Prime Medicine Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2024 California State Teachers Retirement System3,978$28K0.0%-38.9%0.003% 5/16/2024 Levin Capital Strategies L.P.26,500$186K0.0%+32.5%0.022% 5/16/2024 Redmile Group LLC2,074,350$14.52M0.5%+56.6%1.728% 5/15/2024 Price T Rowe Associates Inc. MD2,522,590$17.66M0.0%+13.6%2.102% 5/15/2024 PEAK6 Investments LLC17,000$119K0.0%-22.7%0.014% 5/14/2024 Westwood Holdings Group Inc.159,351$1.12M0.0%N/A0.133% Get the Latest News and Ratings for PRME and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Prime Medicine and its competitors with MarketBeat's FREE daily newsletter. 5/14/2024 EntryPoint Capital LLC7,997$56K0.1%-77.3%0.007% 5/10/2024 Vanguard Group Inc.5,801,445$40.61M0.0%+43.1%4.833% 5/8/2024 ProShare Advisors LLC15,276$107K0.0%+19.8%0.013% 5/7/2024Susquehanna Fundamental Investments LLC21,175$148K0.0%N/A0.018% 5/3/2024 Nikko Asset Management Americas Inc.3,364,663$23.52M0.2%-4.4%2.803% 4/29/2024 China Universal Asset Management Co. Ltd.22,378$157K0.0%+98.8%0.019% 4/19/2024 Sumitomo Mitsui Trust Holdings Inc.3,364,663$23.55M0.0%-4.4%2.805% 4/15/2024 TrueMark Investments LLC85,183$596K0.5%+13.5%0.071% 4/10/2024 Green Alpha Advisors LLC33,738$236K0.2%+14.2%0.028% 2/21/2024Chelsea Counsel Co.5,000$44K0.0%+733.3%0.005% 2/14/2024 Vestal Point Capital LP20,306$180K0.0%N/A0.021% 2/13/2024 Bollard Group LLC361,136$3.20M0.1%N/A0.371% 2/9/2024 Trexquant Investment LP26,983$239K0.0%N/A0.028% 2/8/2024 Nikko Asset Management Americas Inc.3,519,029$31.18M0.3%-3.2%3.616% 2/6/2024 Vestmark Advisory Solutions Inc.144,288$1.28M0.1%N/A0.148% 2/6/2024 Levin Capital Strategies L.P.20,000$177K0.0%N/A0.021% 2/1/2024 New York State Common Retirement Fund8,440$75K0.0%-48.3%0.009% 2/1/2024 Greenwich Wealth Management LLC513,001$4.55M0.4%+16.9%0.527% 1/30/2024 Strs Ohio17,100$151K0.0%N/A0.018% 1/30/2024 Sumitomo Mitsui Trust Holdings Inc.3,519,029$31.18M0.0%-3.2%3.616% 1/24/2024 Mirae Asset Global Investments Co. Ltd.21,301$189K0.0%-7.5%0.022% 1/24/2024 China Universal Asset Management Co. Ltd.11,258$100K0.0%N/A0.012% 1/17/2024 ARK Investment Management LLC3,138,270$27.81M0.2%+19.7%3.225% 1/12/2024 SG Americas Securities LLC10,128$90K0.0%N/A0.010% 1/11/2024 TrueMark Investments LLC75,030$665K0.7%N/A0.077% 1/5/2024 Green Alpha Advisors LLC29,538$262K0.2%-21.9%0.030% 12/18/2023 Vanguard Group Inc.3,951,793$37.70M0.0%+18.5%4.060% 12/6/2023 Citigroup Inc.56,193$536K0.0%+296.8%0.058% 11/14/2023 Profund Advisors LLC21,995$210K0.0%N/A0.023% 11/13/2023 FMR LLC3,922,416$37.42M0.0%-2.9%4.030% 11/13/2023 Rafferty Asset Management LLC128,876$1.23M0.0%N/A0.132% 11/9/2023 Citigroup Inc.56,193$536K0.0%+296.8%0.058% 11/8/2023 Oppenheimer & Co. Inc.21,537$205K0.0%+40.0%0.022% 11/7/2023 Barclays PLC65,140$621K0.0%+726.8%0.067% He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs11/7/2023 Greenwich Wealth Management LLC439,021$4.19M0.4%+111.1%0.451% 10/30/2023 Sumitomo Mitsui Trust Holdings Inc.3,634,848$34.68M0.0%+18.6%3.736% 10/27/2023 Allspring Global Investments Holdings LLC3,067$29K0.0%-73.2%0.003% 10/27/2023 TD Asset Management Inc104,542$997K0.0%+55.9%0.107% 10/26/2023 Mirae Asset Global Investments Co. Ltd.23,016$220K0.0%+22.0%0.024% 10/24/2023 Bank of New York Mellon Corp115,389$1.10M0.0%+11.8%0.119% 10/18/2023 ARK Investment Management LLC2,622,429$25.02M0.2%+7.1%2.695% 10/10/2023 Green Alpha Advisors LLC37,815$361K0.3%+205.3%0.039% 9/21/2023 Barclays PLC7,879$116K0.0%+47.7%0.008% 8/14/2023 Casdin Capital LLC367,175$5.38M0.5%-50.0%0.377% 8/11/2023 Penserra Capital Management LLC8,107$118K0.0%+15.8%0.008% 8/10/2023 Metropolitan Life Insurance Co NY2,203$32K0.0%+206.8%0.002% 8/9/2023 TD Asset Management Inc67,071$983K0.0%+180.4%0.069% 8/7/2023 Principal Financial Group Inc.18,029$264K0.0%N/A0.019% 8/7/2023 Brown Brothers Harriman & Co.10,065$147K0.0%N/A0.010% 8/4/2023 American International Group Inc.19,040$279K0.0%+274.3%0.020% 8/4/2023 Alphabet Inc.11,862,498$173.79M9.3%-10.7%12.200% 7/31/2023 Levin Capital Strategies L.P.20,000$293K0.0%N/A0.021% 7/31/2023 Greenwich Wealth Management LLC208,000$3.05M0.3%-40.4%0.214% 7/31/2023 Sumitomo Mitsui Trust Holdings Inc.3,063,751$44.88M0.0%+207.1%3.151% 7/24/2023 Allspring Global Investments Holdings LLC11,441$168K0.0%+894.0%0.012% 7/18/2023 Allspring Global Investments Holdings LLC11,441$168K0.0%+894.0%0.012% 7/10/2023 ARK Investment Management LLC2,449,199$35.88M0.2%+27.4%2.519% 7/6/2023 Green Alpha Advisors LLC12,386$181K0.1%N/A0.013% (Data available from 1/1/2016 forward) PRME Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PRME shares? During the previous two years, 42 institutional investors and hedge funds held shares of Prime Medicine. The most heavily invested institutionals were Alphabet Inc. ($173.79M), Vanguard Group Inc. ($40.61M), FMR LLC ($37.42M), ARK Investment Management LLC ($27.81M), Sumitomo Mitsui Trust Holdings Inc. ($23.55M), Nikko Asset Management Americas Inc. ($23.52M), and Price T Rowe Associates Inc. MD ($17.66M).Learn more on PRME's institutional investors. What percentage of Prime Medicine stock is owned by institutional investors? 70.37% of Prime Medicine stock is owned by institutional investors. Learn more on PRME's institutional investor holdings. Which institutional investors have been buying Prime Medicine stock? Of the 34 institutional investors that purchased Prime Medicine stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Sumitomo Mitsui Trust Holdings Inc. ($2.64M), Vanguard Group Inc. ($2.36M), ARK Investment Management LLC ($1.22M), Redmile Group LLC ($750K), Bollard Group LLC ($361.14K), Greenwich Wealth Management LLC ($305.00K), and Price T Rowe Associates Inc. MD ($301.43K). How much institutional buying is happening at Prime Medicine? Institutional investors have bought a total of 9,000,059 shares in the last 24 months. This purchase volume represents approximately $91.32M in transactions. Which Prime Medicine major shareholders have been selling company stock? Of the 13 institutional investors that sold Prime Medicine stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Alphabet Inc. ($1.42M), Casdin Capital LLC ($367.18K), Nikko Asset Management Americas Inc. ($270.19K), Sumitomo Mitsui Trust Holdings Inc. ($270.19K), Greenwich Wealth Management LLC ($141K), FMR LLC ($116.80K), and EntryPoint Capital LLC ($27.24K). How much institutional selling is happening at Prime Medicine? Institutional investors have sold a total of 2,648,551 shares in the last 24 months. This volume of shares sold represents approximately $34.09M in transactions. Related Companies: CARGO Therapeutics Major Shareholders REGENXBIO Major Shareholders Mesoblast Major Shareholders ProKidney Major Shareholders Relay Therapeutics Major Shareholders HilleVax Major Shareholders Humacyte Major Shareholders Kyverna Therapeutics Major Shareholders iTeos Therapeutics Major Shareholders Immatics Major Shareholders This page (NYSE:PRME) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceBiden Nomination CANCELED?The Freeport SocietyUrgent Nvidia WarningAltimetryShocking: One AI startup's revenue could surge 4,735%Manward Press"The Biggest Drug Ever" Is ComingBehind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prime Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
